Ayr Wellness Inc. (OTCMKTS:AYRWF) Short Interest Up 20.0% in April

Ayr Wellness Inc. (OTCMKTS:AYRWFGet Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 102,700 shares, a growth of 20.0% from the March 31st total of 85,600 shares. Based on an average trading volume of 348,100 shares, the short-interest ratio is currently 0.3 days.

Several research firms have issued reports on AYRWF. Needham & Company LLC dropped their target price on Ayr Wellness from $28.00 to $21.00 and set a “buy” rating on the stock in a research report on Friday, March 18th. Zacks Investment Research raised Ayr Wellness from a “sell” rating to a “hold” rating in a research note on Tuesday, April 26th. Canaccord Genuity Group reduced their price target on Ayr Wellness from C$57.00 to C$40.00 and set a “buy” rating on the stock in a research note on Friday, March 18th. Finally, Cantor Fitzgerald dropped their price objective on Ayr Wellness from $17.50 to $13.30 and set a “neutral” rating for the company in a report on Friday, March 18th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Ayr Wellness currently has a consensus rating of “Buy” and an average price target of $48.55.

Shares of AYRWF stock opened at $7.39 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.13 and a current ratio of 1.75. The business has a 50 day moving average of $11.50 and a two-hundred day moving average of $14.94. Ayr Wellness has a 52 week low of $7.03 and a 52 week high of $31.87.

Ayr Wellness (OTCMKTS:AYRWFGet Rating) last issued its earnings results on Thursday, March 17th. The company reported ($0.27) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.22) by ($0.05). The company had revenue of $111.77 million during the quarter, compared to analyst estimates of $105.55 million. Ayr Wellness had a negative net margin of 4.74% and a negative return on equity of 6.15%. On average, research analysts forecast that Ayr Wellness will post -0.89 EPS for the current year.

About Ayr Wellness (Get Rating)

Ayr Wellness Inc, a vertically-integrated cannabis multi-state operator, cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizer products. It also provides administrative, consulting, and operations support services to licensed cannabis companies.

Further Reading

Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.